Makarov Danil V, Feuer Zachary, Ciprut Shannon, Lopez Natalia Martinez, Fagerlin Angela, Shedlin Michele, Gold Heather T, Li Huilin, Lynch Gina, Warren Rueben, Ubel Peter, Ravenell Joseph E
VA New York Harbor Healthcare System, 423 E 23rd St, New York, NY, USA.
Departments of Urology, NYU Langone Health, 227 E 30th St, New York, NY, USA.
Trials. 2021 Feb 10;22(1):128. doi: 10.1186/s13063-021-05064-4.
Black men are disproportionately affected by prostate cancer, the most common non-cutaneous malignancy among men in the USA. The United States Preventive Services Task Force (USPSTF) encourages prostate-specific antigen (PSA) testing decisions to be based on shared decision-making (SDM) clinician professional judgment, and patient preferences. However, evidence suggests that SDM is underutilized in clinical practice, especially among the most vulnerable patients. The purpose of this study is to evaluate the efficacy of a community health worker (CHW)-led decision-coaching program to facilitate SDM for prostate cancer screening among Black men in the primary care setting, with the ultimate aim of improving/optimizing decision quality.
We proposed a CHW-led decision-coaching program to facilitate SDM for prostate cancer screening discussions in Black men at a primary care FQHC. This study enrolled Black men who were patients at the participating clinical site and up to 15 providers who cared for them. We estimated to recruit 228 participants, ages 40-69 to be randomized to either (1) a decision aid along with decision coaching on PSA screening from a CHW or (2) receiving a decision aid along with CHW-led interaction on modifying dietary and lifestyle to serve as an attention control. The independent randomization process was implemented within each provider and we controlled for age by dividing patients into two strata: 40-54 years and 55-69 years. This sample size sufficiently powered the detection differences in the primary study outcomes: knowledge, indicative of decision quality, and differences in PSA screening rates. Primary outcome measures for patients will be decision quality and decision regarding whether to undergo PSA screening. Primary outcome measures for providers will be acceptability and feasibility of the intervention. We will examine how decision coaching about prostate cancer screening impact patient-provider communication. These outcomes will be analyzed quantitatively through objective, validated scales and qualitatively through semi-structured, in-depth interviews, and thematic analysis of clinical encounters. Through a conceptual model combining elements of the Preventative Health Care Model (PHM) and Informed Decision-Making Model, we hypothesize that the prostate cancer screening decision coaching intervention will result in a preference-congruent decision and decisional satisfaction. We also hypothesize that this intervention will improve physician satisfaction with counseling patients about prostate cancer screening.
Decision coaching is an evidence-based approach to improve decision quality in many clinical contexts, but its efficacy is incompletely explored for PSA screening among Black men in primary care. Our proposal to evaluate a CHW-led decision-coaching program for PSA screening has high potential for scalability and public health impact. Our results will determine the efficacy, cost-effectiveness, and sustainability of a CHW intervention in a community clinic setting in order to inform subsequent widespread dissemination, a critical research area highlighted by USPSTF.
The trial was registered prospectively with the National Institute of Health registry ( www.clinicaltrials.gov ), registration number NCT03726320 , on October 31, 2018.
美国黑人男性受前列腺癌的影响尤为严重,前列腺癌是美国男性中最常见的非皮肤恶性肿瘤。美国预防服务工作组(USPSTF)鼓励前列腺特异性抗原(PSA)检测决策应基于共同决策(SDM)、临床医生的专业判断以及患者的偏好。然而,有证据表明,SDM在临床实践中未得到充分利用,尤其是在最脆弱的患者群体中。本研究的目的是评估由社区卫生工作者(CHW)主导的决策指导项目在初级保健环境中促进黑人男性进行前列腺癌筛查的共同决策的效果,最终目标是提高/优化决策质量。
我们提出了一个由CHW主导的决策指导项目,以促进在初级保健FQHC对黑人男性进行前列腺癌筛查讨论的共同决策。本研究招募了在参与临床地点就诊的黑人男性患者以及最多15名照顾他们的医护人员。我们估计招募228名年龄在40 - 69岁的参与者,随机分为两组:(1)接受决策辅助工具以及来自CHW的关于PSA筛查的决策指导;(2)接受决策辅助工具以及由CHW主导的关于改变饮食和生活方式的互动,作为注意力对照。独立随机化过程在每个医护人员内部实施,我们通过将患者分为两个年龄层来控制年龄:40 - 54岁和55 - 69岁。这个样本量足以检测主要研究结果中的差异:知识(表明决策质量)以及PSA筛查率的差异。患者的主要结局指标将是决策质量以及是否接受PSA筛查的决策。医护人员的主要结局指标将是干预措施的可接受性和可行性。我们将研究关于前列腺癌筛查的决策指导如何影响医患沟通。这些结局将通过客观、经过验证的量表进行定量分析,并通过半结构化、深入访谈以及临床会诊的主题分析进行定性分析。通过一个结合预防保健模型(PHM)和知情决策模型要素的概念模型,我们假设前列腺癌筛查决策指导干预将导致符合偏好的决策和决策满意度。我们还假设这种干预将提高医生对为患者提供前列腺癌筛查咨询的满意度。
决策指导是一种基于证据的方法,可在许多临床环境中提高决策质量,但对于初级保健中的黑人男性进行PSA筛查,其效果尚未得到充分探索。我们评估由CHW主导的PSA筛查决策指导项目的提议具有很高的可扩展性和公共卫生影响潜力。我们的结果将确定CHW干预在社区诊所环境中的效果、成本效益和可持续性,以便为后续的广泛传播提供信息,这是USPSTF强调的一个关键研究领域。
该试验于2018年10月31日在美国国立卫生研究院注册中心(www.clinicaltrials.gov)进行前瞻性注册,注册号为NCT03726320。